Chimerix Inc (CMRX) Stock: What Does the Chart Say Tuesday?

The market has been high on Chimerix Inc (CMRX) stock recently. CMRX gets a Bullish score from InvestorsObserver Stock Sentiment Indicator.

Chimerix Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on CMRX!

See Full CMRX Report

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With CMRX Stock Today?

Chimerix Inc (CMRX) stock is trading at $1.52 as of 11:53 AM on Tuesday, Jun 6, an increase of $0.06, or 4.11% from the previous closing price of $1.46. The stock has traded between $1.46 and $1.55 so far today. Volume today is light. So far 418,963 shares have traded compared to average volume of 1,122,562 shares.

More About Chimerix Inc

Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through license agreements and a federal contract with the U.S. Biomedical Advanced Research and Development Authority (BARDA) for research and advanced development of drugs to treat various human diseases. The company operates only in one business segment namely pharmaceuticals. Click Here to get the full Stock Report for Chimerix Inc stock.